Table 1.
Pre-treatment control site (ASB) |
Pre-treatment experimental site (ATSB) |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col gut | % Col gut | Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col gut | % Col gut |
3 | F | 90 | 120 | 15.56 | N/Aa | N/A | 3 | F | 90 | 8 | 8.89 | N/Aa | N/A |
M | 11 | 7 | 63.64 | N/A | N/A | M | 11 | 5 | 45.46 | N/A | N/A | ||
5 | F | 100 | 9 | 9.00 | N/A | N/A | 5 | F | 100 | 11 | 11.00 | N/A | N/A |
M | 17 | 12 | 70.59 | N/A | N/A | M | 17 | 12 | 70.59 | N/A | N/A | ||
9 | F | 120 | 8 | 6.67 | N/A | N/A | 9 | F | 120 | 9 | 7.50 | N/A | N/A |
M | 15 | 10 | 66.67 | N/A | N/A | M | 15 | 13 | 86.67 | N/A | N/A | ||
11 | F | 70 | 7 | 10.00 | N/A | N/A | 11 | F | 70 | 4 | 5.71 | N/A | N/A |
M | 8 | 5 | 62.50 | N/A | N/A | M | 8 | 6 | 75.00 | N/A | N/A | ||
Total | F | 380 | 38 | 10.00 | N/A | N/A | Total | F | 380 | 31 | 8.16 | N/A | N/A |
M | 51 | 34 | 66.67 | N/A | N/A | M | 51 | 36 | 71.00 | N/A | N/A |
Post-treatment control site (ASB) |
Post-treatment experimental site (ATSB) |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col gut | % Col gut | Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col gut | % Col gut |
17 | F | 90 | 7 | 7.78 | 4 | 4.44 | 17 | F | 40 | 4 | 10.00 | 0 | 0.00 |
M | 11 | 5 | 45.46 | 5 | 45.46 | M | 2 | 1 | 50.00 | 0 | 0.00 | ||
23 | F | 100 | 3 | 3.00 | 5 | 5.00 | 23 | F | 10 | 0 | 0.00 | 1 | 10.00 |
M | 9 | 3 | 33.33 | 4 | 44.44 | M | 0 | 0 | 0.00 | 0 | 0.00 | ||
29 | F | 160 | 5 | 3.13 | 7 | 4.38 | 26 | F | 35 | 5 | 14.29 | 0 | 0.00 |
M | 20 | 2 | 40.00 | 5 | 25.00 | M | 1 | 0 | 0.00 | 0 | 0.00 | ||
35 | F | 130 | 9 | 6.92 | 4 | 3.08 | 35 | F | 8 | 1 | 12.50 | 0 | 0.00 |
M | 14 | 6 | 42.86 | 4 | 28.57 | M | 0 | 0 | 0.00 | 0 | 0.00 | ||
41 | F | 150 | 6 | 4.00 | 6 | 4.00 | 41 | F | 15 | 2 | 13.33 | 0 | 0.00 |
M | 19 | 3 | 36.84 | 4 | 47.37 | M | 2 | 1 | 50.00 | 0 | 0.00 | ||
Total | F | 630 | 53 | 8.41 | 26 | 4.13 | Total | F | 108 | 12 | 11.11 | 1 | 0.93 |
M | 73 | 29 | 39.72 | 22 | 30.13 | M | 5 | 2 | 40.00 | 0 | 0.00 |
N/A–not applicable; No ASB or ATSB sprayed pre-treatment.